NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Lipoprotein(a) Management Simplified
Lipoprotein(a) Management Simplified: The National Lipid Association Lipid Simplified Series
This document aims to provide practical guidance on testing and management of Lp(a) for primary and secondary ASCVD risk management.
Statin-Drug Interactions
Top Line Results from the Phase 3 Lp(a)HORIZON Trial
On September 4, 2026, Novartis announced the topline results of its phase 3 Lp(a)HORIZON trial. Novartis shared that while pelacarsen lowered lipoprotein(a) [Lp(a)] levels, the…
S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results
Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a significant announcement in triglyceride science…
Industry Innovations | Episode 7: A New Era for FCS: Diagnosis, Daily Life & the Science That’s Changing Everything
Familial chylomicronemia syndrome (FCS) is one of the rarest and most challenging lipid disorders to manage, but the landscape is changing rapidly. In this Industry…
Make Your Voice Heard: Support LDL-C Quality Measurement in the CMS CY 2027 Physician Fee Schedule
The Centers for Medicare & Medicaid Services (CMS) is accepting public comments on the Calendar Year (CY) 2027 Medicare Physician Fee Schedule Proposed Rule, and…
S7E9: HDL Under the Microscope: Setting the Record Straight with Dr. Lipid
In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as “Dr. Lipid”…